secwatch.observer — SEC 8-K summary
======================================

Issuer:     GoodRx Holdings, Inc. (GDRX)
CIK:        0001809519
Form:       8-K
Filed at:   2024-03-07T23:59:59+00:00
Accession:  0001809519-24-000041
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GoodRx CFO Karsten Voermann enters new employment agreement, receives $5M equity and special bonus
--------------------------------------------------------------------------------

- New agreement sets base salary at $450,000, target bonus of 100% of salary, and $5M equity award (50% option, 50% RSU) vesting over 4 years.
- One-time special bonus of $162,792 for contributions to restructuring and management transition.
- Severance provides 12 months base salary, COBRA reimbursement, and accelerated vesting for 12 months if terminated without cause in change-of-control period.
- Voermann remains at-will and subject to confidentiality, non-solicitation covenants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1809519/000180951924000041/0001809519-24-000041-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1809519/000180951924000041/gdrx-8xkxitem502cfoagreeme.htm
  HTML page:      https://secwatch.observer/filing/0001809519-24-000041

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer